Japan sees 'drug lag' as foreign pharmas pass up the market amid pricing pressure, industry group warns

Japan has been leveraging different policy tools to rein in drug expenditures, and that is scaring foreign pharmas away. The country is seeing “trends of a drug lag” as approvals decrease, Yasushi Okada, president of the Japan Pharmaceutical Manufacturers Association and Eisai’s chief operating officer, said.

Related Keywords

Japan ,Japanese ,Yasushi Okada ,Merck Keytruda ,Daiichi Sankyo ,Glaxosmithkline ,Bristol Myers Squibb ,Japan Pharmaceutical Manufacturers Association ,Ono Pharmaceutical ,Opdivo ,Ymriah Tisagenlecleucel ,Trelegy Ellipta ,Drug Prices ,Drug Reimbursement ,Pharma ,Pharma Asia ,